Peptide StackTarget: Multi-systemReproductive

GPL Femme

GPL® Femme · GPL Femme complex · female geroprotector kit · GPL Femme

GPL Femme is a boxed geroprotector kit: thyroid, vessels, brain, liver, and pineal - Thyreogen, Ventfort, Cerluten, Svetinorm, Endoluten. It is not HRT and not Zhenoluten.

Not FDA-approved - research chemical

Quick answer

What it is: GPL Femme is a boxed geroprotector kit: thyroid, vessels, brain, liver, and pineal - Thyreogen, Ventfort, Cerluten, Svetinorm, Endoluten.

Class and target: Commercial multi-organ kit · Multi-system (female kit)

Typical research dose: Kit insert (oral capsules)

Open the calculator →What it is & the evidence on The Bioregulator Atlas →

Research summary, not medical advice.

Reviewed by Kymata Health Editorial Team
Last updated: August 2026Evidence: Low1 peer-reviewed citation
Typical research dose
Kit insert (oral capsules)
Frequency
Manufacturer 10–30 day courses
Half-life
Mixture (kit - not a single PK)
Common vials
N/A (oral)

Use-case scores

0–10 against the evidence we have, not a gym ranking. Hidden domains do not apply here.

  • Longevity / aging2/10

    Boxed kit. Not estradiol. Not a menopause NDA.

Compound card

Class
Commercial female geroprotector kit (oral; not a single peptide)
Status
Not FDA-approved · research use

How it works

GPL Femme is a commercial kit of five organ Cytomaxes (thyroid, vessels, brain, liver, pineal). Zhenoluten (ovary) is not in this kit’s bill of materials.

Source: Cytomed / NPCRIZ commercial kits; class review PMID 11713572

Khavinson map

Adjacent (not padded into the 41)
Class
Commercial multi-organ kit
Organ
Multi-system (female kit)
Target
Multi-system
System
Reproductive
Sequence
Mixture / not a single CAS
Pair
-
GPL Femme

Used in bioregulator stacks

Manufacturer-style organ combinations - not FDA protocols. Every name is a live leaf.

The Khavinson school

GPL Femme is filed here as commercial multi-organ kit, targeting the multi-system (female kit). Khavinson's St. Petersburg group moved from organ extracts (Cytamins) to capsule complexes (Cytomaxes) to synthetic short peptides (Cytogens); most of the evidence comes from that one group, with little independent Western replication.

Read the full background, the proposed epigenetic mechanism, the literature limits, and how we count the canonical 41 on the Khavinson bioregulators index.

History of this molecule

Same commercial idea as GPL Man: one box instead of five Cytomax bottles. The kit lists thyroid, vessels, brain, liver, pineal. Ovary (Zhenoluten) is not in that bill of materials - if someone is shopping “female reproductive bioregulator,” send them to Zhenoluten, not this kit.

We catalog the kit so the name resolves, then we cross-link the leaves.

Caveats

Not estradiol, not progesterone, not a menopause drug. Thyroid-containing kits are still not levothyroxine.

Full 41-map: Khavinson bioregulators index · Bioregulator stacks

Research Use Cases

  • ✓Catalog identity: Low

Dosing

PhaseDoseFrequencyNotes
Kit insertPer boxManufacturer courseCapsules. Not HRT.

Administration

Route / form
Boxed kit of oral capsules. Open the kit into the named leaves. No reconstitution step.
Timing
Morning, with water, about 30 minutes before meals (empty stomach).
Empty stomach?
Yes - Empty stomach - about 30 minutes before meals. Cytomed boxes sometimes print “with food” because they are labeled as supplements; the manufacturer user-guide preference is before meals for absorption.

GPL Femme: Boxed Cytomax kit vs Not a research vial

Boxed Cytomax kit
Bioavailability
Oral capsules. GPL Femme is a commercial five-bottle kit: Thyreogen, Ventfort, Cerluten, Svetinorm, Endoluten. Zhenoluten (ovary) is not in this bill of materials.
Dose note
Follow the kit insert. Otherwise each constituent is a Cytomax course. No reconstitution. Not HRT.
Advantages
  • The real SKU is capsules in a box.
  • Ovary shoppers get sent to Zhenoluten, not this kit.
  • Not a sublingual tablet. Nobody manufactures this SKU that way.
Considerations
  • Not in the 41. Not estradiol, not progesterone, not menopause therapy.
  • Thyroid-containing kits are still not levothyroxine. Keep prescribed thyroid drugs.
  • No kit-level RCT.
Not a research vial
Bioavailability
There is no lyophilized GPL Femme cake. Do not reconstitute a “female geroprotector” powder as if it were this kit.
Dose note
No BAC chart. If the goal is ovary Cytomax, that is Zhenoluten capsules. If the goal is a cytogen vial, open that leaf.
Advantages
  • Keeps the kit from inheriting vial math.
  • Calculator skip is correct.
  • Not an IM extract ampoule.
Considerations
  • Catalogs flatten “female peptide kit” into one syringe. That is a mis-ID.
  • Not a sublingual HRT melt.
  • Animal-source constraints inherit from every constituent.
Recommendation: GPL Femme is a boxed oral Cytomax kit (Thyreogen, Ventfort, Cerluten, Svetinorm, Endoluten). Swallow capsules. It is not HRT, not Zhenoluten, and not a reconstitution job. Open the five leaves. No fake 5 mg vial.

Timeline

Course folklore
Same as the five leaves.

Who it is for

Catalog identity

Low

Search landing for the boxed female geroprotector.

Safety & Considerations

Not estradiol, not a menopause drug. Thyroid kit ≠ levothyroxine.

Regulatory & Legal Status

FDA Status (US)
Research Only
WADA Status (2026)
Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Limits of current evidence

  • Thyroid kit components ≠ levothyroxine.

Verdict

GPL Femme is a kit. Zhenoluten is the ovary Cytomax leaf. This is not HRT.

Interactions & Contraindications

Not estradiol, not a menopause drug. Thyroid kit ≠ levothyroxine.

Frequently Asked Questions

Does GPL Femme include the ovary Cytomax?▼
Not on this kit’s bill of materials. Zhenoluten is the ovary leaf. This kit is neuroendocrine + vascular + hepatic + pineal.
Is it HRT?▼
No.
Oral capsule or injection?▼
Oral capsules in a box. No reconstitution. Not an HRT injection and not Zhenoluten.
Does this include the ovary Cytomax?▼
Not on this kit’s bill of materials. Zhenoluten is the ovary leaf.

References

  1. Khavinson VKh et al. “Tissue-specific effects of peptides.” Bulletin of Experimental Biology and Medicine (2001). PMID: 11713572

📚 Related Articles

Prescription options: compare licensed telehealth providers

Some peptide therapies are available only by prescription after a consult with a licensed clinician.

Compare telehealth →